Coker Ann L, Reeder C Eugene, Fadden Mary Kay, Smith Paige H
University of Texas Health Science Center, School of Public Health, Houston, TX 77030.
Public Health Rep. 2004 Nov-Dec;119(6):557-67. doi: 10.1016/j.phr.2004.09.005.
Little research has addressed differences in health care expenditures among women who are currently experiencing intimate partner violence (IPV) compared with those who are not. The purpose of this work is to provide estimates of direct medical expenditure for physician, drug, and hospital utilization among Medicaid-eligible women who screened as currently experiencing IPV compared with those who are not currently experiencing IPV.
In this family practice-based cross-sectional study, women were screened for current IPV using a 15-item Index of Spouse Abuse-Physical (ISA-P) between 1997 and 1998. Consents were obtained from study subjects to review Medicaid expenditure and utilization data for the same time period.
Mean physician, hospital, and total expenditures were higher for those women with higher IPV scores compared with those who scored as not currently experiencing IPV, after adjusting for confounders. Higher IPV scores were associated with a three-fold increased risk of having a total expenditure over $5,000 (95% confidence interval [CI] 1.3, 8.4). The mean total expenditure difference between the high IPV and no IPV groups was $1,064 (95% CI $623, $1506). The adjusted risk ratio for high IPV score and the log of total Medicaid expenditures was 2.3 (95% CI 1.2, 4.4).
Women screened as experiencing higher IPV scores had higher Medicaid expenditures compared with women not currently experiencing IPV. Early IPV assessment partnered with effective clinic or community-based interventions may help to identify IPV earlier and reduce the health impact and cost of IPV.
与未经历亲密伴侣暴力(IPV)的女性相比,针对当前正经历IPV的女性的医疗保健支出差异的研究较少。本研究的目的是估计符合医疗补助条件的女性中,经筛查当前正经历IPV的女性与未经历IPV的女性在医生诊疗、药物和住院治疗方面的直接医疗支出。
在这项基于家庭医疗的横断面研究中,于1997年至1998年期间,使用包含15个项目的配偶虐待身体指数(ISA-P)对女性进行当前IPV筛查。获得研究对象同意,以查阅同一时期的医疗补助支出和使用数据。
在对混杂因素进行调整后,IPV得分较高的女性的平均医生诊疗支出、住院支出和总支出高于得分显示未经历IPV的女性。IPV得分较高与总支出超过5000美元的风险增加三倍相关(95%置信区间[CI] 1.3, 8.4)。高IPV组与无IPV组之间的平均总支出差异为1064美元(95% CI 623美元,1506美元)。高IPV得分与医疗补助总支出对数的调整风险比为2.3(95% CI 1.2, 4.4)。
与当前未经历IPV的女性相比,经筛查显示经历较高IPV得分的女性的医疗补助支出更高。早期IPV评估与有效的临床或社区干预相结合,可能有助于更早地识别IPV,并减少IPV对健康的影响和成本。